P C Thornton Selected Research

balsalazide (Colazal)

2/2004	Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.
1/2002	A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.
1/2002	A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P C Thornton Research Topics

Disease

3	Ulcerative Colitis 02/2004 - 01/2002
1	Genomic Instability 01/2013

Drug/Important Bio-Agent (IBA)

3	balsalazide (Colazal)FDA LinkGeneric 02/2004 - 01/2002
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2002 - 01/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2013

Therapy/Procedure

2	Therapeutics 02/2004 - 01/2002